$LGL
LGL GROUP INC Stock $lgl

$lgl Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000156459022011892 Filed on March 28, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$7.221M	$28.14M	$7.414M
YoY Change	-2.6%	-9.7%	-16.12%
Cost Of Revenue	$4.735M	$18.07M	$4.552M
YoY Change	4.02%	-10.7%	-15.88%
Gross Profit	$2.486M	$10.07M	$2.862M
YoY Change	-13.14%	-7.85%	-16.51%
Gross Profit Margin	34.43%	35.79%	38.6%
Selling, General & Admin	$3.082M	$8.645M	$3.000M
YoY Change	2.73%	17.27%	24.95%
% of Gross Profit	123.97%	85.84%	104.82%
Research & Development		$2.212M
YoY Change		3.27%
% of Gross Profit		21.96%
Depreciation & Amortization	$159.0K	$501.0K	$136.0K
YoY Change	16.91%	10.6%	6.25%
% of Gross Profit	6.4%	4.97%	4.75%
Operating Expenses	$3.082M	$2.212M	$3.000M
YoY Change	2.73%	3.27%	24.95%
Operating Profit	-$596.0K	-$786.0K	-$138.0K
YoY Change	331.88%	-155.55%	-113.44%
Interest Expense	-$21.25M	$19.53M	-$66.00K
YoY Change	32093.94%	-7254.21%	340.0%
% of Operating Profit
Other Income/Expense, Net	-$269.0K	$19.54M	$159.0K
YoY Change	-269.18%	-17705.41%	20.45%
Pretax Income	-$22.11M	$18.76M	-$45.00K
YoY Change	49040.0%	1338.34%	-103.93%
Income Tax	-$4.962M	$4.118M	$54.00K
% Of Pretax Income		21.96%
Net Earnings	-$17.15M	$14.64M	-$99.00K
YoY Change	17224.24%	1412.19%	-110.26%
Net Earnings / Revenue	-237.52%	52.02%	-1.34%
Basic Earnings Per Share	-$3.25	$2.77
Diluted Earnings Per Share	-$3.247M	$2.744M	-$18.98K
COMMON SHARES
Basic Shares Outstanding	5.282M	5.275M
Diluted Shares Outstanding	5.282M	5.334M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.18M	$45.18M	$24.12M
YoY Change	87.31%	87.31%	33.39%
Cash & Equivalents	$29.02M	$29.02M	$18.33M
Short-Term Investments	$16.17M	$16.17M	$5.791M
Other Short-Term Assets	$494.0K	$494.0K	$257.0K
YoY Change	92.22%	92.22%	-29.59%
Inventory	$5.492M	$5.492M	$5.280M
Prepaid Expenses
Receivables	$4.667M	$4.667M	$4.122M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$55.84M	$55.84M	$33.78M
YoY Change	65.29%	65.29%	16.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.383M	$3.779M	$2.785M
YoY Change	21.47%	17.84%	-1.62%
Goodwill	$40.00K		$40.00K
YoY Change	0.0%		0.0%
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00	$3.072M
YoY Change	-100.0%	-100.0%	-7.86%
Other Assets	$5.000K	$39.00K	$16.00K
YoY Change	-68.75%	-98.73%	-84.31%
Total Long-Term Assets	$4.070M	$4.070M	$9.674M
YoY Change	-57.93%	-57.93%	-6.14%
TOTAL ASSETS
Total Short-Term Assets	$55.84M	$55.84M	$33.78M
Total Long-Term Assets	$4.070M	$4.070M	$9.674M
Total Assets	$59.91M	$59.91M	$43.46M
YoY Change	37.86%	37.86%	10.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.455M	$1.455M	$1.240M
YoY Change	17.34%	15.02%	-33.51%
Accrued Expenses	$2.372M	$2.372M	$2.132M
YoY Change	11.26%	11.26%	-3.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.426M	$4.426M	$3.397M
YoY Change	30.29%	30.29%	-16.82%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$613.0K	$613.0K	$293.0K
YoY Change	109.22%	109.22%	22.08%
Total Long-Term Liabilities	$613.0K	$613.0K	$293.0K
YoY Change	109.22%	109.22%	22.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.426M	$4.426M	$3.397M
Total Long-Term Liabilities	$613.0K	$613.0K	$293.0K
Total Liabilities	$5.163M	$5.163M	$3.690M
YoY Change	39.92%	39.92%	-14.66%
SHAREHOLDERS EQUITY
Retained Earnings	$9.453M		-$5.185M
YoY Change	-282.31%		-15.73%
Common Stock	$45.87M		$45.53M
YoY Change	0.75%		9.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$54.74M	$54.74M	$39.77M
YoY Change
Total Liabilities & Shareholders Equity	$59.91M	$59.91M	$43.46M
YoY Change	37.86%	37.86%	10.81%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$17.15M	$14.64M	-$99.00K
YoY Change	17224.24%	1412.19%	-110.26%
Depreciation, Depletion And Amortization	$159.0K	$501.0K	$136.0K
YoY Change	16.91%	10.6%	6.25%
Cash From Operating Activities	$1.125M	$1.352M	$1.362M
YoY Change	-17.4%	-57.64%	-13.63%
INVESTING ACTIVITIES
Capital Expenditures	-$340.0K	$1.099M	-$78.00K
YoY Change	335.9%	170.02%	-76.85%
Acquisitions
YoY Change
Other Investing Activities	$12.74M	$10.51M	-$21.00K
YoY Change	-60776.19%	-50123.81%
Cash From Investing Activities	$12.40M	$9.406M	-$99.00K
YoY Change	-12627.27%	-2297.66%	-70.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-104.0K	-73.00K	-208.0K
YoY Change	-50.0%	-102.34%	-500.0%
NET CHANGE
Cash From Operating Activities	1.125M	1.352M	1.362M
Cash From Investing Activities	12.40M	9.406M	-99.00K
Cash From Financing Activities	-104.0K	-73.00K	-208.0K
Net Change In Cash	13.42M	10.69M	1.055M
YoY Change	1172.32%	81.78%	-18.34%
FREE CASH FLOW
Cash From Operating Activities	$1.125M	$1.352M	$1.362M
Capital Expenditures	-$340.0K	$1.099M	-$78.00K
Free Cash Flow	$1.465M	$253.0K	$1.440M
YoY Change	1.74%	-90.92%	-24.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y6M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M18D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M18D
CY2021	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021	lgl	Defined Contribution Plan Employers Matching Contribution Vesting Period DefinedContributionPlanEmployersMatchingContributionVestingPeriod	P6Y
CY2021	lgl	Term Of Warranty TermOfWarranty	P1Y
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	208000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	189000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20837000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20336000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3383000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2785000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	396000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	422000
CY2020Q4	lgl	Equity Investment In Unconsolidated Subsidiary EquityInvestmentInUnconsolidatedSubsidiary	3072000
CY2020Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	327000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	55836000
CY2021Q4	us-gaap	Land Land	536000
CY2020Q4	us-gaap	Land Land	536000
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	4869000
CY2020Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	4810000
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	18815000
CY2020Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17775000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24220000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23121000
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3052000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16000
CY2020Q4	us-gaap	Assets Assets	43455000
CY2021	us-gaap	Manufacturing Costs ManufacturingCosts	18069000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1240000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1324000
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	599000
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	25000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	823000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	808000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4426000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3397000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	124000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	613000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	293000
CY2021Q4	us-gaap	Liabilities Liabilities	5163000
CY2020Q4	us-gaap	Liabilities Liabilities	3690000
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5446840
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5308973
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5409550
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5272204
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	53000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	53000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	45817000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	45477000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9453000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5185000
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	81584
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	81584
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	580000
CY2020Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	580000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	54743000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	39765000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59906000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43455000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28140000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31162000
CY2020	us-gaap	Manufacturing Costs ManufacturingCosts	20233000
CY2021	lgl	Gain Loss On Equity Investment In Unconsolidated Subsidiary GainLossOnEquityInvestmentInUnconsolidatedSubsidiary	59453000
CY2020	lgl	Gain Loss On Equity Investment In Unconsolidated Subsidiary GainLossOnEquityInvestmentInUnconsolidatedSubsidiary	-262000
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-16962000
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	74000
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-22949000
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	139000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19542000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-111000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18756000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1304000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14638000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	336000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.77
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	85000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3254000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	202000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	39765000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	178000
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	251000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	413000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	54743000
CY2021	us-gaap	Profit Loss ProfitLoss	14638000
CY2020	us-gaap	Profit Loss ProfitLoss	968000
CY2021	us-gaap	Depreciation Depreciation	501000
CY2020	us-gaap	Depreciation Depreciation	453000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	75000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	75000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	413000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	790000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	59453000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-262000
CY2021	lgl	Realized Loss On Sale Of Marketable Securities RealizedLossOnSaleOfMarketableSecurities	17377000
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-22949000
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	139000
CY2021	lgl	Non Cash Donation Of Irnt Common Stock NonCashDonationOfIRNTCommonStock	-1318000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3142000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	255000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	545000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-323000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	212000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-736000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	226000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-194000
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	574000
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-8000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	801000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-717000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1352000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3192000
CY2021	lgl	Payments To Subscription Agreement Funding PaymentsToSubscriptionAgreementFunding	2725000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1099000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	407000
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	18548000
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	5318000
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	21000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9406000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-428000
CY2020	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	3254000
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	202000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	178000
CY2021	lgl	Payment For Taxes Related To Net Share Settlement Of Equity Awards PaymentForTaxesRelatedToNetShareSettlementOfEquityAwards	251000
CY2020	lgl	Payment For Taxes Related To Net Share Settlement Of Equity Awards PaymentForTaxesRelatedToNetShareSettlementOfEquityAwards	23000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-73000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3114000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10685000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5878000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18331000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12453000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29016000
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Uses of Estimates</p>The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18331000
CY2021	lgl	Non Cash Distribution Of Iron Net Securities By Sponsor NonCashDistributionOfIronNetSecuritiesBySponsor	65250000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	3000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	72000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	60000
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	22000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	212000
CY2021	us-gaap	Depreciation Depreciation	501000
CY2020	us-gaap	Depreciation Depreciation	453000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	212000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	287000
CY2021Q4	us-gaap	Goodwill Goodwill	40000
CY2020Q4	us-gaap	Goodwill Goodwill	40000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	75000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	75000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	26000
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	80000
CY2020Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	21000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2212000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2142000
CY2021	lgl	Warrants To Purchase Common Shares WarrantsToPurchaseCommonShares	1051664
CY2020	lgl	Warrants To Purchase Common Shares WarrantsToPurchaseCommonShares	1051664
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5275374
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5173430
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	58713
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	43429
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5334087
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5216859
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-379000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	458000
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration Risks</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:5pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2021, the Company's largest customer,<span style="color:#FF0000;"> </span>a commercial aerospace and defense company, accounted for $7,870,000, or 28.0%,<span style="color:#FF0000;"> </span>of the Company's total revenues, compared to $7,810,000, or 25.1%, of the Company’s total revenues in 2020.<span style="color:#FF0000;"> </span>The Company’s second largest customer, a defense contractor, accounted for $3,138,000, or 11.2%,<span style="color:#FF0000;"> </span>of the Company's total revenues, compared to $5,550,000, or 17.8%,<span style="font-family:Calibri;"> </span>of the Company’s total revenues<span style="font-family:Calibri;"> </span>in 2020.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:5pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A significant portion of the Company's accounts receivable is concentrated with a relatively small number of customers. As of December 31, 2021, four of the Company's largest customers accounted for approximately $2,595,000, or 53.2%, of accounts receivable. As of December 31, 2020, four of the Company's largest customers accounted for approximately $2,301,000, or 53.4%, of accounts receivable. The Company carefully evaluates the creditworthiness of its customers in deciding to extend credit and utilizes letters of credit to further limit credit risk for export sales. As a result of these policies, the Company has experienced very low historical bad debt expense and believes the related risk to be minimal.</p>At various times throughout the year and at December 31, 2021 and 2020, some deposits held at financial institutions were in excess of federally insured limits. The Company has not experienced any losses related to these balances.
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	11000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-95000
CY2019Q4	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	3350000
CY2019Q4	lgl	Proceeds From Subscription Of Investment ProceedsFromSubscriptionOfInvestment	2725000
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-16962000
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	74000
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-22949000
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	139000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-6000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	31000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	50000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	976000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	81000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3188000
CY2021Q4	us-gaap	Assets Under Management Carrying Amount AssetsUnderManagementCarryingAmount	15595000
CY2020Q4	us-gaap	Assets Under Management Carrying Amount AssetsUnderManagementCarryingAmount	19063000
CY2021	lgl	Fund Management Fee Percent FundManagementFeePercent	0.0050
CY2021Q4	lgl	Number Of Mutual Fund Investment NumberOfMutualFundInvestment	4
CY2020Q4	lgl	Number Of Mutual Fund Investment NumberOfMutualFundInvestment	2
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2065000
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1428000
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1219000
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2314000
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2080000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2196000
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2467000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	982000
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	733000
CY2021Q4	us-gaap	Inventory Net InventoryNet	5492000
CY2020Q4	us-gaap	Inventory Net InventoryNet	5280000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	860000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	116000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	448000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	31000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-271000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	45000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	116000
CY2020	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	125000
CY2021	lgl	Income Tax Reconciliation Tax Credit Expiration IncomeTaxReconciliationTaxCreditExpiration	0
CY2020	lgl	Income Tax Reconciliation Tax Credit Expiration IncomeTaxReconciliationTaxCreditExpiration	132000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	238000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-7000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	1000
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	332000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	1000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	32000
CY2021	lgl	Deferred Income Tax Expense Benefit Before Change In Valuation Allowance DeferredIncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	3521000
CY2020	lgl	Deferred Income Tax Expense Benefit Before Change In Valuation Allowance DeferredIncomeTaxExpenseBenefitBeforeChangeInValuationAllowance	264000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-379000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-9000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3142000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	255000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4118000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	336000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3939000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	274000
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-38000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-379000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-9000
CY2021	lgl	Income Tax Reconciliation Change In Uncertain Tax Positions IncomeTaxReconciliationChangeInUncertainTaxPositions	458000
CY2020	lgl	Income Tax Reconciliation Change In Uncertain Tax Positions IncomeTaxReconciliationChangeInUncertainTaxPositions	0
CY2021	lgl	Income Tax Reconciliation Provision To Return IncomeTaxReconciliationProvisionToReturn	13000
CY2020	lgl	Income Tax Reconciliation Provision To Return IncomeTaxReconciliationProvisionToReturn	15000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	33000
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	10000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4118000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	336000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.220
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.258
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	345000
CY2020Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	286000
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	44000
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	58000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	262000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	338000
CY2021Q4	lgl	Deferred Tax Liabilities Unrealized Gains On Marketable Securities DeferredTaxLiabilitiesUnrealizedGainsOnMarketableSecurities	1024000
CY2020Q4	lgl	Deferred Tax Liabilities Unrealized Gains On Marketable Securities DeferredTaxLiabilitiesUnrealizedGainsOnMarketableSecurities	27000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	6000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	1717000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	892000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	23000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	252000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	34000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	35000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	984000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1074000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3528000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	97000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	379000
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	12000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	318000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	458000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	90000
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	3052000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	90000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	429000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	29000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	458000
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	458000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	80000000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	541000000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	611000000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	396000000
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	422000000
CY2021Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	135000000
CY2020Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	129000000
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	25000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	138000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	138000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	138000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	11000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	425000
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	29000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	396000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2020Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	12.50
CY2020Q4	lgl	Common Stock Distribution Value CommonStockDistributionValue	5258320000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Method Used ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsMethodUsed	The expected life of 5 years was based on the estimated term of the Common Stock Warrants, the volatility factor of 46.5% was based on historical volatilities of the Company’s common stock and the exercise price of $12.50 per share of the Company’s common stock was based on the terms of the warrant agreement.
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	13000000.0
CY2021	lgl	Common Stock Issuance Cost CommonStockIssuanceCost	202000
CY2011Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	100000
CY2021Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	540000
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2020	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	81584
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	580000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	58050
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.56
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.37
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	236000
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	33050
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.41
CY2021	lgl	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue	1.12
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.72
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.02
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.72
CY2021Q4	lgl	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	4.02
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.50
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	113000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	119000
CY2021	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.20
CY2021	lgl	Vesting Percentage Of Employer Contributions By Year Six VestingPercentageOfEmployerContributionsByYearSix	1
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28140000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31162000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-786000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	1415000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11000
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-11000
CY2021	lgl	Gain Loss On Equity Investment In Unconsolidated Subsidiary GainLossOnEquityInvestmentInUnconsolidatedSubsidiary	59453000
CY2020	lgl	Gain Loss On Equity Investment In Unconsolidated Subsidiary GainLossOnEquityInvestmentInUnconsolidatedSubsidiary	-262000
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-16962000
CY2020	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	74000
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-22949000
CY2020	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	139000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19542000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-111000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18756000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1304000
CY2021	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	1099000
CY2020	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	407000
CY2021Q4	us-gaap	Assets Assets	59906000
CY2020Q4	us-gaap	Assets Assets	43455000
CY2021	lgl	Right To Receive Common Stock Share RightToReceiveCommonStockShare	1

Files In Submission

Name	View Source	Status
0001564590-22-011892-index-headers.html	Edgar Link	pending
0001564590-22-011892-index.html	Edgar Link	pending
0001564590-22-011892.txt	Edgar Link	pending
0001564590-22-011892-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lgl-10k_20211231.htm	Edgar Link	pending
lgl-10k_20211231_htm.xml	Edgar Link	completed
lgl-20211231.xsd	Edgar Link	pending
lgl-20211231_cal.xml	Edgar Link	unprocessable
lgl-20211231_def.xml	Edgar Link	unprocessable
lgl-20211231_lab.xml	Edgar Link	unprocessable
lgl-20211231_pre.xml	Edgar Link	unprocessable
lgl-ex211_7.htm	Edgar Link	pending
lgl-ex231_12.htm	Edgar Link	pending
lgl-ex311_11.htm	Edgar Link	pending
lgl-ex312_6.htm	Edgar Link	pending
lgl-ex321_9.htm	Edgar Link	pending
lgl-ex322_10.htm	Edgar Link	pending
lgl-ex44_8.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LGL
LGL GROUP INC Stock $lgl

2021 Q4 Form 10-K Financial Statement

#000156459022011892 Filed on March 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGL LGL GROUP INC Stock $lgl

2021 Q4 Form 10-K Financial Statement

#000156459022011892 Filed on March 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LGL
LGL GROUP INC Stock $lgl